期刊
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE
卷 4, 期 2, 页码 102-109出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ncpcardio0768
关键词
atherosclerosis; CETP; HDL cholesterol; lipoproteins; therapy
Plasma concentrations of HDL cholesterol are inversely correlated with risk of coronary heart disease, and low HDL-cholesterol levels are a risk factor even in patients aggressively treated for LDL reduction. Thus, there is great interest in targeting HDL cholesterol therapeutically. The existing approaches are limited in their ability to raise HDL-cholesterol levels, and there has, therefore, been a major focus on the development of novel therapies. The goal of new approaches is to either raise HDL-cholesterol levels or improve the function of HDL. Here, the current status of the development of novel therapies targeted toward HDL metabolism is reviewed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据